Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cutaneous manifestations of lymphoid-variant hypereosinophilic syndrome.
Laurent C, Lefèvre G, Kahn JE, Staumont-Salle D, Felten R, Puget M, Moulinet T, Machelart I, Launay D, Charvet E, Bouaziz JD, Jachiet M, Espitia A, Mahr A, Le Clech C, Malphettes M, Morice C, Mourah S, Moins-Teisserenc H, Lifermann F, Soulier-Guérin K, Villate A, Baillou C, Grados A, Robbins A, Abisror N, Bagot M, Boutboul D, Panel K, Vignon-Pennamen MD, Rivet J, Battistella M, Groh M, de Masson A; CEREO network. Laurent C, et al. Among authors: abisror n. Br J Dermatol. 2022 Dec;187(6):1011-1013. doi: 10.1111/bjd.21782. Epub 2022 Aug 12. Br J Dermatol. 2022. PMID: 35862277 Free PMC article.
Abnormal T-cell phenotype in episodic angioedema with hypereosinophilia (Gleich syndrome): Frequency, clinical implication, and prognosis.
Abisror N, Mekinian A, Dechartres A, Groh M, Berezne A, Noel N, Morati C, Haroche J, Hunault-Berger M, Agard C, Ackermann F, Geffray L, Jeandel PY, Trouillier S, Quemeneur T, Dufour JF, Lamaury I, Lhote F, Lefèvre G, Fain O, Kahn JE; French Eosinophil Network. Abisror N, et al. J Am Acad Dermatol. 2023 May;88(5):e243-e250. doi: 10.1016/j.jaad.2019.02.001. Epub 2019 Feb 7. J Am Acad Dermatol. 2023. PMID: 30738125
Venous thrombosis and predictors of relapse in eosinophil-related diseases.
Réau V, Vallée A, Terrier B, Plessier A, Abisror N, Ackermann F, Benainous R, Bohelay G, Chabi-Charvillat ML, Cornec D, Desbois AC, Faguer S, Freymond N, Gaillet A, Hamidou M, Killian M, Le Jeune S, Marchetti A, Meyer G, Osorio-Perez F, Panel K, Rautou PE, Rohmer J, Simon N, Tcherakian C, Vasse M, Zuelgaray E, Lefevre G, Kahn JE, Groh M. Réau V, et al. Among authors: abisror n. Sci Rep. 2021 Mar 18;11(1):6388. doi: 10.1038/s41598-021-85852-9. Sci Rep. 2021. PMID: 33737704 Free PMC article.
Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus.
Chasset F, Jaume L, Mathian A, Abisror N, Dutheil A, Barbaud A, Kottler D, Girard C, Jousse-Joulin S, Tauber M, Livideanu CB, Avettand-Fenoel V, Lhote R, Pha M, Amoura Z; EMSED (Etude des maladies systémiques en dermatologie) study group. Chasset F, et al. Among authors: abisror n. J Am Acad Dermatol. 2023 Jul;89(1):171-173. doi: 10.1016/j.jaad.2023.02.044. Epub 2023 Mar 5. J Am Acad Dermatol. 2023. PMID: 36878316 No abstract available.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study.
Guédon AF, Catano J, Ricard L, Laurent C, de Moreuil C, Urbanski G, Deriaz S, Gerotziafas G, Elalamy I, Audemard A, Chasset F, Alamowitch S, Sellam J, Maillot F, Boffa JJ, Cohen A, Abisror N, Fain O, Mekinian A. Guédon AF, et al. Among authors: abisror n. Arthritis Res Ther. 2022 Jan 25;24(1):33. doi: 10.1186/s13075-022-02726-9. Arthritis Res Ther. 2022. PMID: 35078523 Free PMC article.
Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study.
Guedon AF, Ricard L, Laurent C, De Moreuil C, Urbanski G, Deriaz S, Gerotziafas G, Elalamy I, Audemard A, Chasset F, Alamowitch S, Sellam J, Boffa JJ, Cohen A, Wahl C, Abisror N, Maillot F, Fain O, Mekinian A. Guedon AF, et al. Among authors: abisror n. RMD Open. 2023 Mar;9(1):e002881. doi: 10.1136/rmdopen-2022-002881. RMD Open. 2023. PMID: 36894193 Free PMC article.
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study.
de Frémont GM, Costedoat-Chalumeau N, Lazaro E, Belkhir R, Guettrot-Imbert G, Morel N, Nocturne G, Molto A, Goulenok T, Diot E, Perard L, Ferreira-Maldent N, Le Besnerais M, Limal N, Martis N, Abisror N, Debouverie O, Richez C, Sobanski V, Maurier F, Sauvetre G, Levesque H, Timsit MA, Tieulié N, Orquevaux P, Bienvenu B, Mahevas M, Papo T, Lartigau-Roussin C, Chauvet E, Berthoux E, Sarrot-Reynauld F, Raffray L, Couderc M, Silva NM, Jourde-Chiche N, Belhomme N, Thomas T, Poindron V, Queyrel-Moranne V, Delforge J, Le Ray C, Pannier E, Mariette X, Le Guern V, Seror R; GR2 Study Group. de Frémont GM, et al. Among authors: abisror n. Lancet Rheumatol. 2023 Jun;5(6):e330-e340. doi: 10.1016/S2665-9913(23)00099-1. Epub 2023 May 8. Lancet Rheumatol. 2023. PMID: 38251600
Discoid drug-induced lupus erythematosus induced by antitumor necrosis factor agents is a very rare subtype of cutaneous lupus: Three cases and literature review.
Brehon A, Moguelet P, Guégan S, Abisror N, Barbaud A, Beal C, Laffitte E, Fain O, Francès C, Chasset F. Brehon A, et al. Among authors: abisror n. Dermatol Ther. 2020 May;33(3):e13364. doi: 10.1111/dth.13364. Epub 2020 Apr 20. Dermatol Ther. 2020. PMID: 32239589 Review. No abstract available.
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study.
Murarasu A, Guettrot-Imbert G, Le Guern V, Yelnik C, Queyrel V, Schleinitz N, Ferreira-Maldent N, Diot E, Urbanski G, Pannier E, Lazaro E, Souchaud-Debouverie O, Orquevaux P, Belhomme N, Morel N, Chauvet E, Maurier F, Le Besnerais M, Abisror N, Goulenok T, Sarrot-Reynauld F, Deroux A, Pasquier E, de Moreuil C, Bezanahary H, Pérard L, Limal N, Langlois V, Calas A, Godeau B, Lavigne C, Hachulla E, Cohen F, Benhamou Y, Raffray L, de Menthon M, Tieulié N, Poindron V, Mouthon L, Larosa M, Eléfant E, Sentilhes L, Molto A, Deneux-Tharaux C, Costedoat-Chalumeau N; GR2 Study Group. Murarasu A, et al. Among authors: abisror n. Lancet Rheumatol. 2022 Dec;4(12):e842-e852. doi: 10.1016/S2665-9913(22)00308-3. Epub 2022 Nov 24. Lancet Rheumatol. 2022. PMID: 38261392
39 results